BelHealth Investment Partners

BelHealth Investment Partners is a healthcare-focused private equity firm specializing in lower middle market companies across the United States. The firm typically invests between $20 million and $50 million per platform company, targeting sectors such as services, products, distribution, and information technology within the healthcare industry. BelHealth seeks to acquire majority positions in entrepreneur-owned companies that can benefit from its extensive operating and private equity investment expertise.

Founded in 2011, BelHealth has a unique combination of investing, executive management, and entrepreneurial experience, which it leverages to achieve superior investment returns. The firm employs an active, hands-on approach to support management, drive revenue and profit growth, and achieve superior returns for its investors and partners. BelHealth's team has completed over 100 healthcare transactions, with a total value exceeding $1 billion.

In August 2024, BelHealth completed the sale of VFP Pharmacy Group, one of the largest independent national fertility pharmacies in the United States. This exit highlights BelHealth's successful track record in building and exiting healthcare businesses. The firm's commitment to fostering innovative healthcare solutions and supporting the growth of its partners underscores its position as a key player in the healthcare investment landscape.